[go: up one dir, main page]

TR201203086A2 - Pharmaceutical dosage form comprising cefixime and clavulanic acid. - Google Patents

Pharmaceutical dosage form comprising cefixime and clavulanic acid.

Info

Publication number
TR201203086A2
TR201203086A2 TR2012/03086A TR201203086A TR201203086A2 TR 201203086 A2 TR201203086 A2 TR 201203086A2 TR 2012/03086 A TR2012/03086 A TR 2012/03086A TR 201203086 A TR201203086 A TR 201203086A TR 201203086 A2 TR201203086 A2 TR 201203086A2
Authority
TR
Turkey
Prior art keywords
cefixime
clavulanic acid
dosage form
pharmaceutical dosage
clavulanic
Prior art date
Application number
TR2012/03086A
Other languages
Turkish (tr)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2012/03086A priority Critical patent/TR201203086A2/en
Publication of TR201203086A2 publication Critical patent/TR201203086A2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Mevcut buluş, aktif ajan olarak sefiksim ve klavulanik asit ve/veya türevlerini içeren farmasötik bileşimlere ilişkindir.The present invention relates to pharmaceutical compositions comprising cefixime and clavulanic acid and / or derivatives as the active agent.

TR2012/03086A 2010-05-14 2010-05-14 Pharmaceutical dosage form comprising cefixime and clavulanic acid. TR201203086A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TR2012/03086A TR201203086A2 (en) 2010-05-14 2010-05-14 Pharmaceutical dosage form comprising cefixime and clavulanic acid.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2012/03086A TR201203086A2 (en) 2010-05-14 2010-05-14 Pharmaceutical dosage form comprising cefixime and clavulanic acid.

Publications (1)

Publication Number Publication Date
TR201203086A2 true TR201203086A2 (en) 2012-08-22

Family

ID=47004707

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2012/03086A TR201203086A2 (en) 2010-05-14 2010-05-14 Pharmaceutical dosage form comprising cefixime and clavulanic acid.

Country Status (1)

Country Link
TR (1) TR201203086A2 (en)

Similar Documents

Publication Publication Date Title
MX2015008627A (en) Boronic acid derivatives and therapeutic uses thereof.
MX2016016666A (en) Boronic acid derivatives and therapeutic uses thereof.
MX2016015093A (en) Boronic acid derivatives and therapeutic uses thereof.
PT3061454T (en) VETERINARY ORAL PARASITICID COMPOSITIONS INCLUDING ACTIVE AGENTS OF SYSTEMIC ACTION, METHODS AND THEIR USES
EA201591003A1 (en) DERIVATIVES OF BORONIC ACID AND THEIR THERAPEUTIC APPLICATION
AR081681A1 (en) METHODS AND COMPOSITIONS FOR THE INTRATECAL ADMINISTRATION OF b-GALACTOCEREBROSIDASA
UA109010C2 (en) MORPHOLINOPYRIMIDINES AND THEIR APPLICATIONS IN THERAPY
MX2013001677A (en) Stable formulations of linaclotide.
EA201201050A1 (en) PYRAZOLES AS AN ANTAGONISTS CRTH2
PH12014501967B1 (en) Benzodioxanes in combination with other actives for inhibiting leukotriene production
EA201590805A1 (en) COMPOSITION WITH IMMEDIATE AND PROLONGED DELIVERY
EA201291211A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING HYDROMORPHONE AND NALOXONE
EA201400822A1 (en) DERIVATIVES OF HETEROCYCLIC AMIDES AS AN ANTAGONISTS OF P2HRECEPTOR
MX344846B (en) COMBINATION OF ACTIVE LOADED GRANULES WITH ADDITIONAL ASSETS.
UA115357C2 (en) Pyridin-4-yl derivatives
NZ708821A (en) Lfa-1 inhibitor formulations
TR201009394A2 (en) Improved montelukast formulations.
CY1119064T1 (en) Fibrolytic compositions containing bromelain and natokinase for the prevention and treatment of pulmonary conditions
TR200909785A1 (en) Pharmaceutical compositions containing cefdinir as the active agent.
EA201500446A1 (en) PHARMACEUTICAL COMPOSITION TO REDUCE N-OXIDE TRIMETYLAMINE LEVEL
UA116994C2 (en) STABILIZED AMORPHIC FORM OF AGOMELATIN, THE METHOD OF ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
TR201203086A2 (en) Pharmaceutical dosage form comprising cefixime and clavulanic acid.
TR201109160A2 (en) New pharmaceutical compositions containing eplerenone.
TR201009399A2 (en) Rapidly soluble effervescent rosuvastatin formulations.
TR201203083A2 (en) Pharmaceutical dosage form comprising cefdinir and clavulanic acid.